Bithiol may be available in the countries listed below.
Ingredient matches for Bithiol
Ichthammol is reported as an ingredient of Bithiol in the following countries:
- Belgium
International Drug Name Search
Bithiol may be available in the countries listed below.
Ichthammol is reported as an ingredient of Bithiol in the following countries:
International Drug Name Search
Cardio Aliv may be available in the countries listed below.
Acetylsalicylic Acid is reported as an ingredient of Cardio Aliv in the following countries:
International Drug Name Search
Durodor may be available in the countries listed below.
Fentanyl is reported as an ingredient of Durodor in the following countries:
International Drug Name Search
Burinex may be available in the countries listed below.
UK matches:
Bumetanide is reported as an ingredient of Burinex in the following countries:
International Drug Name Search
Glossary
SPC | Summary of Product Characteristics (UK) |
Bleo-Cell may be available in the countries listed below.
Bleomycin sulfate (a derivative of Bleomycin) is reported as an ingredient of Bleo-Cell in the following countries:
International Drug Name Search
The following drugs and medications are in some way related to, or used in the treatment of Brain Tumor. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
See sub-topics
Micromedex Care Notes:
Medical Encyclopedia:
Harvard Health Guide:
Benzylpenicillin Cooper may be available in the countries listed below.
Benzylpenicillin sodium (a derivative of Benzylpenicillin) is reported as an ingredient of Benzylpenicillin Cooper in the following countries:
International Drug Name Search
Brivirac may be available in the countries listed below.
Brivudine is reported as an ingredient of Brivirac in the following countries:
International Drug Name Search
Treating high blood pressure in the lungs (pulmonary arterial hypertension [PAH]). It may also be used for other conditions as determined by your doctor.
Sildenafil Injection is a phosphodiesterase type 5 (PDE5) inhibitor. It works by relaxing and dilating the blood vessels in the lungs. This lowers the blood pressure in the lungs and helps to improve your ability to exercise.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Sildenafil Injection. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Sildenafil Injection. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Sildenafil Injection may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Sildenafil Injection as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Sildenafil Injection.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Diarrhea; dizziness; flushing; headache; mild pain, redness, or swelling at the injection site; muscle aches; nausea; nosebleed; numb or tingling skin; stuffy or runny nose; trouble sleeping; upset stomach.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; confusion; fainting; fast or irregular heartbeat; fever; memory loss; numbness of an arm or leg; one-sided weakness; painful or prolonged erection; persistent or severe pain, redness, or swelling at the injection site; ringing in the ears; seizure; severe or persistent dizziness or nosebleed; severe or persistent vision changes; shortness of breath; speech problems; sudden decrease or loss of hearing; sudden decrease or loss of vision in one or both eyes.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Sildenafil side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include fainting; prolonged erection; severe dizziness.
Sildenafil Injection is usually handled and stored by a health care provider. If you are using Sildenafil Injection at home, store Sildenafil Injection as directed by your pharmacist or health care provider. Keep Sildenafil Injection out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Sildenafil Injection. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Bisoprolol comp.-CT may be available in the countries listed below.
Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Bisoprolol comp.-CT in the following countries:
Hydrochlorothiazide is reported as an ingredient of Bisoprolol comp.-CT in the following countries:
International Drug Name Search
Infracyanine may be available in the countries listed below.
Indocyanine Green is reported as an ingredient of Infracyanine in the following countries:
International Drug Name Search
Bomba may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Bioallethrin is reported as an ingredient of Bomba in the following countries:
Piperonyl Butoxide is reported as an ingredient of Bomba in the following countries:
International Drug Name Search
Cefpodoxime Ratiopharm may be available in the countries listed below.
Cefpodoxime proxetil (a derivative of Cefpodoxime) is reported as an ingredient of Cefpodoxime Ratiopharm in the following countries:
International Drug Name Search
Buprenodale may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Buprenorphine hydrochloride (a derivative of Buprenorphine) is reported as an ingredient of Buprenodale in the following countries:
International Drug Name Search
Crinohermal may be available in the countries listed below.
Estradiol is reported as an ingredient of Crinohermal in the following countries:
Fluprednidene 21-acetate (a derivative of Fluprednidene) is reported as an ingredient of Crinohermal in the following countries:
International Drug Name Search
Brucen may be available in the countries listed below.
Glibenclamide is reported as an ingredient of Brucen in the following countries:
International Drug Name Search
Bupranololo may be available in the countries listed below.
Bupranololo (DCIT) is also known as Bupranolol (Rec.INN)
International Drug Name Search
Glossary
DCIT | Denominazione Comune Italiana |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Benylin Dry Cough may be available in the countries listed below.
Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Benylin Dry Cough in the following countries:
International Drug Name Search
Rec.INN
J05AB15
0069304-47-8
C11-H13-Br-N2-O5
333
Antiviral agent
(E)-5-(2-bromovinyl)-2'-deoxyuridine
International Drug Name Search
Glossary
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Bicalutamida QT Farma may be available in the countries listed below.
Bicalutamide is reported as an ingredient of Bicalutamida QT Farma in the following countries:
International Drug Name Search
Omeprazolo Hexal may be available in the countries listed below.
Omeprazole is reported as an ingredient of Omeprazolo Hexal in the following countries:
International Drug Name Search
Doxycyclin AL may be available in the countries listed below.
Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Doxycyclin AL in the following countries:
Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Doxycyclin AL in the following countries:
Doxycycline monohydrate (a derivative of Doxycycline) is reported as an ingredient of Doxycyclin AL in the following countries:
International Drug Name Search
Biafineact may be available in the countries listed below.
Trolamine is reported as an ingredient of Biafineact in the following countries:
International Drug Name Search
In the US, Quasense (ethinyl estradiol/levonorgestrel systemic) is a member of the drug class contraceptives and is used to treat Abnormal Uterine Bleeding, Birth Control, Endometriosis, Gonadotropin Inhibition, Ovarian Cysts and Polycystic Ovary Syndrome.
US matches:
Ethinylestradiol is reported as an ingredient of Quasense in the following countries:
Levonorgestrel is reported as an ingredient of Quasense in the following countries:
International Drug Name Search
Blocadren Depot may be available in the countries listed below.
Timolol maleate (a derivative of Timolol) is reported as an ingredient of Blocadren Depot in the following countries:
International Drug Name Search
Bétahistine RPG may be available in the countries listed below.
Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Bétahistine RPG in the following countries:
International Drug Name Search
Beezocain may be available in the countries listed below.
Benzocaine is reported as an ingredient of Beezocain in the following countries:
International Drug Name Search
Apo-Metoprolol-L may be available in the countries listed below.
Metoprolol is reported as an ingredient of Apo-Metoprolol-L in the following countries:
International Drug Name Search
See also: Generic Seasonale
Seasonique is a brand name of ethinyl estradiol/levonorgestrel, approved by the FDA in the following formulation(s):
A generic version of Seasonique has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Seasonique and have been approved by the FDA:
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Seasonique. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Equibactin may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Sulfadiazine is reported as an ingredient of Equibactin in the following countries:
Trimethoprim is reported as an ingredient of Equibactin in the following countries:
International Drug Name Search
Brinerdin may be available in the countries listed below.
Clopamide is reported as an ingredient of Brinerdin in the following countries:
Dihydroergocristine is reported as an ingredient of Brinerdin in the following countries:
Dihydroergocristine mesilate (a derivative of Dihydroergocristine) is reported as an ingredient of Brinerdin in the following countries:
Reserpine is reported as an ingredient of Brinerdin in the following countries:
International Drug Name Search
Amoxicilina Fecofar may be available in the countries listed below.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicilina Fecofar in the following countries:
International Drug Name Search
NeoCitran Hustenstiller may be available in the countries listed below.
Butamirate citrate (a derivative of Butamirate) is reported as an ingredient of NeoCitran Hustenstiller in the following countries:
International Drug Name Search
Carbenin may be available in the countries listed below.
Betamipron is reported as an ingredient of Carbenin in the following countries:
Panipenem is reported as an ingredient of Carbenin in the following countries:
International Drug Name Search
Blocanol may be available in the countries listed below.
Timolol maleate (a derivative of Timolol) is reported as an ingredient of Blocanol in the following countries:
International Drug Name Search
Vasomet may be available in the countries listed below.
Terazosin hydrochloride (a derivative of Terazosin) is reported as an ingredient of Vasomet in the following countries:
International Drug Name Search
Blocanol Depot may be available in the countries listed below.
Timolol maleate (a derivative of Timolol) is reported as an ingredient of Blocanol Depot in the following countries:
International Drug Name Search
Rec.INN
S01KX
0000306-94-5
C10-F18
462
Diagnostic agent
Octadecafluorodecahydronaphtalene
International Drug Name Search
Glossary
BAN | British Approved Name |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Bexistar may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Bexistar in the following countries:
International Drug Name Search
Rubrum may be available in the countries listed below.
Granisetron is reported as an ingredient of Rubrum in the following countries:
International Drug Name Search
Lowpres may be available in the countries listed below.
Clonidine hydrochloride (a derivative of Clonidine) is reported as an ingredient of Lowpres in the following countries:
International Drug Name Search
Péridys may be available in the countries listed below.
Domperidone is reported as an ingredient of Péridys in the following countries:
International Drug Name Search
Bio-Glibenclamide may be available in the countries listed below.
Glibenclamide is reported as an ingredient of Bio-Glibenclamide in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Rec.INN
0005486-03-3
C20-H27-N-O5
361
Antiprotozoal: Agent against coccidiosis
3-Quinolinecarboxylic acid, 4-hydroxy-6,7-bis(2-methylpropoxy)-, ethyl ester
International Drug Name Search
Glossary
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Silbecor may be available in the countries listed below.
Sulfadiazine silver (a derivative of Sulfadiazine) is reported as an ingredient of Silbecor in the following countries:
International Drug Name Search
Bupivacain-Morfin SDA may be available in the countries listed below.
Bupivacaine hydrochloride (a derivative of Bupivacaine) is reported as an ingredient of Bupivacain-Morfin SDA in the following countries:
Morphine hydrochloride (a derivative of Morphine) is reported as an ingredient of Bupivacain-Morfin SDA in the following countries:
International Drug Name Search
Burnil may be available in the countries listed below.
Tetryzoline hydrochloride (a derivative of Tetryzoline) is reported as an ingredient of Burnil in the following countries:
International Drug Name Search
Bupivacain-Fentanyl Sintetica may be available in the countries listed below.
Bupivacaine hydrochloride (a derivative of Bupivacaine) is reported as an ingredient of Bupivacain-Fentanyl Sintetica in the following countries:
Fentanyl citrate (a derivative of Fentanyl) is reported as an ingredient of Bupivacain-Fentanyl Sintetica in the following countries:
International Drug Name Search
Cetirizine HCl 5 mg
Pseudoephedrine HCl 120 mg
Antihistamine
Nasal Decongestant
taking tranquilizers or sedatives.
In case of overdose, get medical help or contact a Poison Control Center right away.
adults and children 12 years and over | take 1 tablet every 12 hours; do not take more than 2 tablets in 24 hours. |
adults 65 years and over | ask a doctor |
children under 12 years of age | ask a doctor |
consumers with liver or kidney disease | ask a doctor |
colloidal silicon dioxide, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, talc, yellow iron oxide
1-888-423-0139
Original Prescription Strength
12 Hour
All Day Allergy D
Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets, 5 mg/120 mg
antihistamine/nasal decongestant
Allergy & Congestion
12 Hour Relief of: Sneezing, Runny Nose, Sinus Pressure, Itchy, Watery Eyes, Itchy Throat or Nose, Nasal Congestion
Indoor & Outdoor Allergies
Actual Size
Compare to Zyrtec-D® active ingredients
All Day Allergy D Carton
Topcare All Day Allergy D cetirizine hcl, pseudoephedrine hcl tablet, extended release | ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
ANDA | ANDA077170 | 05/19/2008 |
Labeler - Topco Associates LLC (006935977) |
Bupverine may be available in the countries listed below.
Propiverine hydrochloride (a derivative of Propiverine) is reported as an ingredient of Bupverine in the following countries:
International Drug Name Search
Dermades may be available in the countries listed below.
Desonide is reported as an ingredient of Dermades in the following countries:
International Drug Name Search
Burana may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Burana in the following countries:
International Drug Name Search
Definition of Enterobiasis: A common intestinal parasitic infection which primarily affects children.
The following drugs and medications are in some way related to, or used in the treatment of Enterobiasis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
mye-koe-FEN-oh-late MOE-fe-til
Increased susceptibility to infection and the possible development of lymphoma may result from immunosuppression. Only physicians experienced in immunosuppressive therapy and management of organ transplant recipients should prescribe, and they should have complete information requisite for the follow-up of the patient. Female contraception must be used due to increased risk of congenital malformations and pregnancy loss .
In the U.S.
Available Dosage Forms:
Therapeutic Class: Immune Suppressant
Mycophenolate belongs to a group of medicines known as immunosuppressive agents. It is used with other medicines to lower the body's natural immunity in patients who receive organ transplants (e.g., kidney, heart, or liver).
When a patient receives an organ transplant, the body's white blood cells will try to get rid of (reject) the transplanted organ. Mycophenolate prevents the white blood cells from rejecting the transplanted organ.
mycophenolate mofetil is available only with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For mycophenolate mofetil, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to mycophenolate mofetil or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of mycophenolate in children receiving kidney transplants. However, safety and efficacy have not been established in infants younger than 3 months of age.
Appropriate studies have not been performed on the relationship of age to the effects of mycophenolate in children receiving heart or liver transplants. Safety and efficacy have not been established.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of mycophenolate in the elderly. However, elderly patients are more likely to have age-related liver, kidney, or heart problems, which may require caution and an adjustment in the dose for patients receiving mycophenolate.
Pregnancy Category | Explanation | |
---|---|---|
All Trimesters | D | Studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy in a life threatening situation or a serious disease, may outweigh the potential risk. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking mycophenolate mofetil, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using mycophenolate mofetil with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using mycophenolate mofetil with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of mycophenolate mofetil. Make sure you tell your doctor if you have any other medical problems, especially:
Take mycophenolate mofetil exactly as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered. Taking too much may increase the chance of side effects, while taking too little may lead to rejection of your transplanted organ.
mycophenolate mofetil should come with a medication guide. Read and follow these instructions carefully. Ask your doctor if you have any questions.
It is best to take mycophenolate mofetil on an empty stomach, either one hour before or 2 hours after meals, unless your doctor tells you otherwise.
Mycophenolate capsules and tablets should be swallowed whole. Do not break, crush, open, or chew them.
It is important that you handle mycophenolate mofetil with care. Avoid inhaling the powder from the capsule or allowing the powder or the oral liquid to touch your skin or eyes. If the medicine gets on your skin, wash it thoroughly with soap and water. If the medicine gets in your eyes, wash them with plain water. Should a spill occur, wipe it up using paper towels wetted with water to remove the powder or liquid.
You should use the oral dispenser from the pharmacist to measure the correct amount of suspension. If you have any questions about this, ask your doctor or pharmacist.
Use only the brand of mycophenolate tablets that your doctor ordered. Different brands may not work the same way.
If you are also using antacids that contain aluminum or magnesium (such as Maalox® or Mylanta®), do not use them at the same time as mycophenolate. Use them 1 hour before or 2 hours after your dose. If you have questions, talk with your doctor about the best times to use your medicines.
The dose of mycophenolate mofetil will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of mycophenolate mofetil. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of mycophenolate mofetil, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
The oral suspension can also be kept in the refrigerator. Throw away any unused suspension after 60 days.
It is very important that your doctor check your progress at regular visits. Your doctor will do blood tests to make sure that mycophenolate is working properly and to check for unwanted effects.
Using mycophenolate mofetil while you are pregnant can harm your unborn baby. If you are a woman who can bear children, your doctor may give you a pregnancy test before you start using mycophenolate mofetil to make sure you are not pregnant. Your birth control pills may not work as well while you are using mycophenolate mofetil. You must use two forms of birth control together for 1 month before starting mycophenolate mofetil, for the entire time that you are being treated, and for 6 weeks after you receive your last dose of mycophenolate mofetil. Use birth control pills together with another form of birth control, such as a condom, diaphragm, or contraceptive foam or jelly. If you think you have become pregnant while using the medicine, tell your doctor right away.
Using mycophenolate mofetil may increase your risk of getting skin cancer or cancer of the lymph system (lymphoma). Talk to your doctor if you have concerns about this risk.
Use sunscreen or sunblock lotions with a sun protection factor (SPF) of at least 15 on a regular basis when you are outdoors. Wear protective clothing and hats and stay out of direct sunlight, especially between the hours of 10 a.m. and 3 p.m. Avoid sunlamps and tanning beds.
Mycophenolate can temporarily lower the number of white blood cells in your blood, which increases the chance of getting an infection. If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you have a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.
Mycophenolate may cause pure red cell aplasia (PRCA). This is a very rare condition where the body no longer makes red blood cells and the patient has severe anemia. Check with your doctor right away if you have a fever and sore throat; pale skin; unusual bleeding or bruising; or unusual tiredness or weakness.
mycophenolate mofetil may increase your risk of developing a serious and rare brain infection called progressive multifocal leukoencephalopathy (PML). Check with your doctor right away if you are having more than one of these symptoms: vision changes, loss of coordination, clumsiness, memory loss, difficulty speaking or understanding what others say, and weakness in the legs.
mycophenolate mofetil may increase your risk of developing a rare and serious virus infection called BK virus-associated nephropathy (BKVAN). The BK virus may affect how your kidneys work and cause a transplanted kidney to fail. Check with your doctor right away if you are having more than one of these symptoms: bloody urine; a decreased frequency or amount of urine; increased thirst; loss of appetite; lower back or side pain; nausea; swelling of the face, fingers, or lower legs; trouble with breathing; unusual tiredness or weakness; vomiting; or weight gain.
While you are receiving mycophenolate, and after you stop, do not have any immunizations (vaccinations) without your doctor's approval. Mycophenolate will lower your body's resistance and there is a chance you might get the infection the immunization is meant to prevent.
Do not stop taking mycophenolate mofetil without checking first with your doctor. Doing so may cause rejection of your transplanted organ. Your doctor will decide how long you should take mycophenolate mofetil.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: mycophenolate mofetil side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.